Assessment of diagnostic criteria between primary cutaneous anaplastic large‐cell lymphoma and CD30‐rich transformed mycosis fungoides; a study of 66 cases

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|6|1547-1554

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.6, 2015-06, pp. : 1547-1554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD30‐rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 6, 2015-06 ,pp. : 1478-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large‐cell lymphoma: what is the cost?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1474-1475

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of Mycosis Fungoides after CD30 Positive Anaplastic Large Cell Lymphoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 7, 2000-07 ,pp. : 458-461

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of Ki‐1 Positive Anaplastic Large Cell Lymphoma Transformed from Mycosis Fungoides

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 9, 1996-09 ,pp. : 606-613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30‐positive lymphoproliferative disease

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 784-788

John Wiley & Sons Inc

Access to resources Recommend Favorite